298 related articles for article (PubMed ID: 22325485)
21. HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway.
Ade N; Leon F; Pallardy M; Peiffer JL; Kerdine-Romer S; Tissier MH; Bonnet PA; Fabre I; Ourlin JC
Toxicol Sci; 2009 Feb; 107(2):451-60. PubMed ID: 19033392
[TBL] [Abstract][Full Text] [Related]
22. Functional Role of NRF2 in Cervical Carcinogenesis.
Ma JQ; Tuersun H; Jiao SJ; Zheng JH; Xiao JB; Hasim A
PLoS One; 2015; 10(8):e0133876. PubMed ID: 26247201
[TBL] [Abstract][Full Text] [Related]
23. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.
Eades G; Yang M; Yao Y; Zhang Y; Zhou Q
J Biol Chem; 2011 Nov; 286(47):40725-33. PubMed ID: 21926171
[TBL] [Abstract][Full Text] [Related]
24. Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome.
Muscarella LA; Barbano R; D'Angelo V; Copetti M; Coco M; Balsamo T; la Torre A; Notarangelo A; Troiano M; Parisi S; Icolaro N; Catapano D; Valori VM; Pellegrini F; Merla G; Carella M; Fazio VM; Parrella P
Epigenetics; 2011 Mar; 6(3):317-25. PubMed ID: 21173573
[TBL] [Abstract][Full Text] [Related]
25. Methylation Density Pattern of
Fabrizio FP; Sparaneo A; Centra F; Trombetta D; Storlazzi CT; Graziano P; Maiello E; Fazio VM; Muscarella LA
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159323
[TBL] [Abstract][Full Text] [Related]
26. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
[TBL] [Abstract][Full Text] [Related]
27. A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells.
Guo D; Wu B; Yan J; Li X; Sun H; Zhou D
Biochem Biophys Res Commun; 2012 Nov; 428(1):80-5. PubMed ID: 23047008
[TBL] [Abstract][Full Text] [Related]
28. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
[TBL] [Abstract][Full Text] [Related]
29. Cytoprotection against beta-amyloid (Aβ) peptide-mediated oxidative damage and autophagy by Keap1 RNAi in human glioma U87mg cells.
Youn P; Chen Y; Furgeson DY
Neurosci Res; 2015 May; 94():70-8. PubMed ID: 25612817
[TBL] [Abstract][Full Text] [Related]
30. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.
Yang M; Yao Y; Eades G; Zhang Y; Zhou Q
Breast Cancer Res Treat; 2011 Oct; 129(3):983-91. PubMed ID: 21638050
[TBL] [Abstract][Full Text] [Related]
31. Calcium-sensing receptor silencing in colorectal cancer is associated with promoter hypermethylation and loss of acetylation on histone 3.
Fetahu IS; Höbaus J; Aggarwal A; Hummel DM; Tennakoon S; Mesteri I; Baumgartner-Parzer S; Kállay E
Int J Cancer; 2014 Nov; 135(9):2014-23. PubMed ID: 24691920
[TBL] [Abstract][Full Text] [Related]
32. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin.
Tanigawa S; Fujii M; Hou DX
Free Radic Biol Med; 2007 Jun; 42(11):1690-703. PubMed ID: 17462537
[TBL] [Abstract][Full Text] [Related]
33. UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis.
Abu-Alainin W; Gana T; Liloglou T; Olayanju A; Barrera LN; Ferguson R; Campbell F; Andrews T; Goldring C; Kitteringham N; Park BK; Nedjadi T; Schmid MC; Slupsky JR; Greenhalf W; Neoptolemos JP; Costello E
J Pathol; 2016 Feb; 238(3):423-33. PubMed ID: 26497117
[TBL] [Abstract][Full Text] [Related]
34. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds.
MacLeod AK; McMahon M; Plummer SM; Higgins LG; Penning TM; Igarashi K; Hayes JD
Carcinogenesis; 2009 Sep; 30(9):1571-80. PubMed ID: 19608619
[TBL] [Abstract][Full Text] [Related]
36. Identification of methylation-silenced genes in colorectal cancer cell lines: genomic screening using oligonucleotide arrays.
Fukutomi S; Seki N; Koda K; Miyazaki M
Scand J Gastroenterol; 2007 Dec; 42(12):1486-94. PubMed ID: 17994469
[TBL] [Abstract][Full Text] [Related]
37. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
38. The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells.
Zuo Q; Wu R; Xiao X; Yang C; Yang Y; Wang C; Lin L; Kong AN
J Cell Biochem; 2018 Nov; 119(11):9573-9582. PubMed ID: 30129150
[TBL] [Abstract][Full Text] [Related]
39. Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer.
Sadeghi MR; Jeddi F; Soozangar N; Somi MH; Shirmohamadi M; Khaze V; Samadi N
Biomed Pharmacother; 2018 Aug; 104():458-464. PubMed ID: 29793178
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation.
Khor TO; Huang Y; Wu TY; Shu L; Lee J; Kong AN
Biochem Pharmacol; 2011 Nov; 82(9):1073-8. PubMed ID: 21787756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
